• costs of outside consultants and contractors engaged in research and development activities, including their fees and travel expenses;

filing / Aug 6, 2026 / receipt

During the three months ended June 30, 2025, the Company recorded a one-time restructuring charge of $ 1.2 million related to the May 2025 workforce reduction, including employee severance, benefits and related termination costs and are included under the caption “Restructuring charge” in the Company’s consolidated statement of operations and comprehensive loss.

filing / Aug 6, 2026 / receipt

Restructuring Charges In May 2025, we announced a strategic plan to streamline our operations, including a workforce reduction of approximately 20%, and in November 2025 announced a further workforce reduction of approximately 34%.

filing / Aug 6, 2026 / receipt

• any future headcount growth and associated costs, should we expand our research and development efforts; • the cost of expanding, maintaining and enforcing our intellectual property portfolio, including filing, prosecuting, defending and enforcing our patent claims and other intellectual property rights; • the cost of defending potential intellectual property disputes, including patent infringement actions brou

filing / Aug 6, 2026 / receipt

These cost containment measures (be it federal or state regulations, or regional bidding processes, or most-favored-nation pricing practices, or otherwise) could reduce the ultimate demand for any approved development candidates and or put pressure on our pricing, which could negatively affect our business, financial condition, results of operations and prospects.

filing / Aug 6, 2026 / receipt

• costs of outside consultants and contractors engaged in research and development activities, including their fees and travel expenses;

filing / May 7, 2026 / receipt

The remaining payments related to the November 2025 workforce reduction are 15 expected to be paid by the third quarter of 2026.

filing / May 7, 2026 / receipt

The following is a summary of the activity for the November 2025 Workforce Reduction: Employee separation costs Balance at December 31, 2025 $ 1,893 Adjustments 41 Cash payments ( 1,278 ) Balance at March 31, 2026 $ 656 16 Item 2.

filing / May 7, 2026 / receipt

• any future headcount growth and associated costs, should we expand our research and development efforts; • the cost of expanding, maintaining and enforcing our intellectual property portfolio, including filing, prosecuting, defending and enforcing our patent claims and other intellectual property rights; • the cost of defending potential intellectual property disputes, including patent infringement actions brou

filing / May 7, 2026 / receipt

These cost containment measures (be it federal or state regulations, or regional bidding processes, or most-favored-nation pricing practices, or otherwise) could reduce the ultimate demand for any approved development candidates and or put pressure on our pricing, which could negatively affect our business, financial condition, results of operations and prospects.

filing / May 7, 2026 / receipt

Senior Clinical Trial Manager | {"ats": "lever", "city": null, "state": null, "job_id": "b83b2e51-b237-41f3-b657-456124e65a2d", "remote": false, "category": "other", "function": "clinical", "location"

company_statement / Sep 15, 2026 / receipt

Scientist I, Biology | {"ats": "lever", "city": null, "state": null, "job_id": "3b9dc977-ba3e-4766-a57b-b8534a639582", "remote": false, "category": "other", "function": "other", "location": "60 First

company_statement / Aug 27, 2026 / receipt